2025 Challenges facing CFOs: Reinvention for the Pharma Future

In this episode of Deep Dive, we highlight key challenges affecting CFOs that are shaping the pharmaceutical industry in 2025 and beyond. Big changes like AI-driven innovation in drug development, shifting market dynamics, a focus on personalized medicine and advanced therapies, and growing emphasis on sustainability and ESG. To stay competitive, companies and CFOs must prioritize R&D investments, data-driven strategies, and strategic collaborations.